The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines
Open accessAbstract
Using genome-wide expression profiling of a panel of 27 human mammary cell lines with different mechanisms of E-cadherin inactivation, we evaluated the relationship between E-cadherin status and gene expression levels. Expression profiles of cell lines with E-cadherin (CDH1) promoter methylation were significantly different from those with CDH1 expression or, surprisingly, those with CDH1 truncating mutations. Furthermore, we found no significant differentially expressed genes between cell lines with wild-type and mutated CDH1. The expression profile complied with the fibroblastic morphology of the cell lines with promoter methylation, suggestive of epithelial-mesenchymal transition (EMT). All other lines, also the cases with CDH1 mutations, had epithelial features. Three non-tumorigenic mammary cell lines derived from normal breast epithelium also showed CDH1 promoter methylation, a fibroblastic phenotype and expression profile. We suggest that CDH1 promoter methylation, but not mutational inactivation, is part of an entire programme, resulting in EMT and increased invasiveness in breast cancer. The molecular events that are part of this programme can be inferred from the differentially expressed genes and include genes from the TGFbeta pathway, transcription factors involved in CDH1 regulation (i.e. ZFHX1B, SNAI2, but not SNAI1, TWIST), annexins, AP1/2 transcription factors and members of the actin and intermediate filament cytoskeleton organisation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Karin, M., Liu, Z.-G., & Zandi, E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80068-3 · Cited by 2,893
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Systematic variation in gene expression patterns in human cancer cell lines
Ross, D. T., Scherf, U., Eisen, M. B., Perou, C. M., Rees, C., Spellman, P., Iyer, V., Jeffrey, S. S., Van de Rijn, M., Waltham, M., et al. (2000) · Nature Genetics · doi:10.1038/73432 · Cited by 2,088
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656 · cited 1×
“In view of its function in adhesion, it is considered as an invasion suppressor, which is indeed corroborated by in vitro experiments (Vleminckx et al, 1991).”
BackgroundMorphogenetic roles of classic cadherins
Takeichi, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80102-2 · Cited by 1,450
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
The SLUG zinc-finger protein represses E-cadherin in breast cancer.
Hajra, K. M., Chen, D. Y., & Fearon, E. R. (2002) · PubMed · Cited by 1,020
Nuclear localization of β-catenin by interaction with transcription factor LEF-1
Huber, O., Korn, R., McLaughlin, J., Ohsugi, M., Herrmann, B. G., & Kemler, R. (1996) · Mechanisms of Development · doi:10.1016/0925-4773(96)00597-7 · Cited by 856
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., Berx, G., Cano, A., Beug, H., & Foisner, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208429 · Cited by 808
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W. B., Pitha, P. M., Davidson, N. E., & Baylin, S. B. (1995) · PubMed · Cited by 796
Relevance of Breast Cancer Cell Lines as Models for Breast Tumours: An Update
Lacroix, M., & Leclercq, G. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000014042.54925.cc · Cited by 782
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Self-citationE-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
Becker, K., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., & Höfler, H. (1994) · PubMed · Cited by 767
The transcriptional repressor Snail promotes mammary tumor recurrence
Moody, S. E., Perez, D., Pan, T.-C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.009 · Cited by 750
limmaGUI: A graphical user interface for linear modeling of microarray data
Wettenhall, J. M., & Smyth, G. K. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth449 · Cited by 722
Maretzky, T., Reiss, K., Ludwig, A., Buchholz, J., Scholz, F., Proksch, E., de Strooper, B., Hartmann, D., & Saftig, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500918102 · Cited by 673
Cadherin superfamily genes: functions, genomic organization, and neurologic diversity
Yagi, T., & Takeichi, M. (2000) · Genes & Development · doi:10.1101/gad.14.10.1169 · Cited by 637
(1990) · PubMed · Cited by 612
Mutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Thompson, E. W., Paik, S., Brünner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., et al. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500314 · Cited by 523
Berx, G., Cleton-Jansen, A., Strumane, K., de Leeuw, W. J., Nollet, F., Roy, F. M. V., & Cornelisse, C. J. (1996) · PubMed · Cited by 461
Self-citationMethylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer
Grady, W. M., Willis, J., Guilford, P. J., Dunbier, A. K., Toro, T. T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.-G., et al. (2000) · Nature Genetics · doi:10.1038/79120 · Cited by 447
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
A systematic profile of DNA methylation in human cancer cell lines.
Paz, M. F., Fraga, M. F., Avila, S., Guo, M., Pollán, M., Herman, J. G., & Esteller, M. (2003) · PubMed · Cited by 367
E-Cadherin Gene Promoter Hypermethylation in Primary Human Gastric Carcinomas
Tamura, G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.569 · Cited by 352
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
Vos, C., Cleton-Jansen, A., Berx, G., de Leeuw, W., ter Haar, N., van Roy, F., Cornelisse, C., Peterse, J., & van de Vijver, M. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.523 · Cited by 347
Self-citationde Leeuw, W. J. F., Berx, G., Vos, C. B. J., Peterse, J. L., Van de Vijver, M. J., Litvinov, S., Van Roy, F., Cornelisse, C. J., & Cleton-Jansen, A.-M. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199712)183:4<404::aid-path1148>3.0.co;2-9 · Cited by 306
Self-citationSiitonen, S. M., Kononen, J. T., Helin, H. J., Rantala, I. S., Holli, K. A., & Isola, J. J. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.4.394 · Cited by 302
Differentiation state and invasiveness of human breast cancer cell lines
Sommers, C. L., Byers, S. W., Thompson, E. W., Torri, J. A., & Gelmann, E. P. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666165 · Cited by 270
De Craene, B., Gilbert, B., Stove, C., Bruyneel, E., van Roy, F., & Berx, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3545 · Cited by 254
Molecular cytogenetic analysis of 11 new breast cancer cell lines
Forozan, F., Veldman, R., Ammerman, C. A., Parsa, N. Z., Kallioniemi, A., Kallioniemi, O.-P., & Ethier, S. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6695007 · Cited by 219
Smith, L. M., Wise, S. C., Hendricks, D. T., Sabichi, A. L., Bos, T., Reddy, P., Brown, P. H., & Birrer, M. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202989 · Cited by 213
Transformation by ras modifies AP1 composition and activity
Mechta, F., Lallemand, D., Pfarr, C. M., & Yaniv, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200900 · Cited by 212
Regulatory mechanisms controlling human E-cadherin gene expression
Liu, Y.-N., Lee, W.-W., Wang, C.-Y., Chao, T.-H., Chen, Y., & Chen, J. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208991 · Cited by 209
Pérez-Losada, J., Sánchez-Martı́n, M., Rodrı́guez-Garcı́a, A., Sánchez, M. L., Orfao, A., Flores, T., & Sánchez-Garcı́a, I. (2002) · Blood · doi:10.1182/blood.v100.4.1274.h81602001274_1274_1286 · Cited by 182
Ethier, S. P., Mahacek, M. L., Gullick, W. J., Frank, T. S., & Weber, B. L. (1993) · PubMed · Cited by 176
Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak
Winter, M. J., Nagelkerken, B., Mertens, A. E. E., Bakker, H. A. M., Bruijn, I. H. B., & Litvinov, S. V. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00045-9 · Cited by 172
Receptor tyrosine kinases expressed in metastatic colon cancer
Craven, R. J., Xu, L., Weiner, T. M., Fridell, Y.-W. C., Dent, G. A., Srivastava, S., Varnum, B. C., Liu, E. T., & Cance, W. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600611 · Cited by 165
Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells.
Sommers, C. L., Gelmann, E. P., Kemler, R., Cowin, P., & Byers, S. W. (1994) · PubMed · Cited by 164
Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering, M., Barker, N., Harkes, I. C., van der Heyden, M. A. G., Dijk, N. J., Hollestelle, A., Klijn, J. G. M., Clevers, H. C., & Schutte, M. E. M. (2001) · PubMed · Cited by 163
Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
Hiraguri, S., Godfrey, T. E., Nakamura, H., Graff, J. R., Collins, C. C., Shayesteh, L., Doggett, N. A., Johnson, K. J., Wheelock, M. J., Herman, J. G., et al. (1998) · PubMed · Cited by 149
Clinical significance of AXL kinase family in gastric cancer.
Wu, C.-W., Li, A. F., Chi, C., Lai, C.-H., Huang, C. L., Lo, S.-S., Lui, W.-Y., & Lin, W. (2002) · PubMed · Cited by 123
Sokol, J. P., Neil, J. R., Schiemann, B. J., & Schiemann, W. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1312 · Cited by 83
Milde‐Langosch, K., Bamberger, A., Methner, C., Rieck, G., & Löning, T. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<468::aid-ijc2>3.0.co;2-r · Cited by 69
Protein kinases in normal and transformed melanocytes
Quong, R. Y. Y., Blckford, S. T., Ing, Y. L., Terman, B. I., Herlyn, M., & Lassam, N. J. (1994) · Melanoma Research · doi:10.1097/00008390-199410000-00008 · Cited by 51
Adnane, J., Seijo, E., Chen, Z., Bizouarn, F. A., Leal, M., Sebti, S. M., & Muñoz-Antonia, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104367200 · Cited by 49
Expression analysis of candidate breast tumour suppressor genes on chromosome 16q
van Wezel, T., Lombaerts, M., Roon, E. H. J. V., Philippo, K., Baelde, H. J., Szuhai, K., Cornelisse, C. J., & Cleton-Jansen, A. (2005) · Breast Cancer Research · doi:10.1186/bcr1337 · Cited by 43
Self-citationInfiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors
Lombaerts, M., Middeldorp, J. W., van der Weide, E., Philippo, K., van Wezel, T., Smit, V. T. H. B. M., Cornelisse, C. J., & Cleton-Jansen, A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.041 · Cited by 25
Self-citation
Cited by
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The cell-cell adhesion molecule E-cadherin
van Roy, F., & Berx, G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8281-1 · Cited by 1,325
Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Metadata
- Authors
- Lombaerts, M., van Wezel, T., Philippo, K., Dierssen, J. W. F., Zimmerman, R. M. E., Oosting, J., van Eijk, R., Eilers, P. H., van de Water, B., Cornelisse, C. J., & Cleton-Jansen, A.-M.
- Venue
- British Journal of Cancer
- Published
- 2006-02-21
- Volume
- 94
- Issue
- 5
- Pages
- 661-671
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1992968941
- Cited by
- 346
- References
- 56
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.